Spots Global Cancer Trial Database for matched unrelated donor
Every month we try and update this database with for matched unrelated donor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies | NCT05316701 | Acute Myeloid L... Acute Lymphoid ... Mixed Phenotype... Undifferentiate... Myelodysplastic... Acute Leukemia Therapy-Related... | Orca-T Standard-of-Car... | 18 Years - 65 Years | Orca Biosystems, Inc. | |
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies | NCT05316701 | Acute Myeloid L... Acute Lymphoid ... Mixed Phenotype... Undifferentiate... Myelodysplastic... Acute Leukemia Therapy-Related... | Orca-T Standard-of-Car... | 18 Years - 65 Years | Orca Biosystems, Inc. | |
Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT | NCT00516152 | Chronic Myeloid... Acute Myelogeno... Myelodysplasia Acute Lymphocyt... Severe Aplastic... Non-Hodgkin's L... Lymphoprolifera... Multiple Myelom... Advanced Myelop... | Busulfan/Fludar... | 15 Years - 61 Years | University of California, San Francisco | |
Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies | NCT04013685 | Acute Myeloid L... Acute Lymphoid ... Myelodysplastic... Acute Leukemia Blastic Plasmac... Chronic Myeloid... | Orca-T | 18 Years - 75 Years | Orca Biosystems, Inc. | |
T&B Depletion Non Malignant | NCT01810926 | Graft Versus Ho... | polyclonal anti... Rituximab Treosulfan Fludarabine Thiotepa Cyclosporine A Methotrexate Methotrexate | 28 Days - 64 Years | Bambino Gesù Hospital and Research Institute | |
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies | NCT05316701 | Acute Myeloid L... Acute Lymphoid ... Mixed Phenotype... Undifferentiate... Myelodysplastic... Acute Leukemia Therapy-Related... | Orca-T Standard-of-Car... | 18 Years - 65 Years | Orca Biosystems, Inc. |